Concepedia

Publication | Closed Access

Prediction of persistent gestational trophobalstic neoplasia: The role of hCG level and ratio in 2weeks after evacuation of complete mole

DOI

27

Citations

13

References

2011

Year

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim
Gynecologic Oncology

References

YearCitations

Risk and prognostic factors in trophoblastic neoplasia

K. D. Bagshawe

Cancer

1976

413

HYDATIDIFORM MOLE. DIAGNOSIS, MANAGEMENT, AND LONG-TERM FOLLOWUP OF 347 PATIENTS

Stephen Curry, Charles B. Hammond, Lee Tyrey,

Obstetrical & Gynecological Survey

1975

251

The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment

E.I. Kohorn

International Journal of Gynecological Cancer

2001

225

Clinical and laboratory correlates of molar pregnancy and trophoblastic disease

C. Paul Morrow, Oscar A. Kletzky, Philip J. DiSaia,

American Journal of Obstetrics and Gynecology

1977

116

Low Risk of Relapse After Achieving Undetectable hCG Levels in Women With Complete Molar Pregnancy

Adam Wolfberg, Colleen M. Feltmate, Donald P. Goldstein,

Obstetrics and Gynecology

2004

90

A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance.

David R. Genest, O Laborde, Ross S. Berkowitz,

PubMed

1991

72

Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.

Schlaerth Jb, Morrow Cp, Kletzky Oa,

PubMed

1981

67

Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut.

Kohorn Ei

PubMed

1982

63

Subsequent pregnancy experience in patients with gestational trophoblastic disease. New England Trophoblastic Disease Center, 1965-1992.

Ross S. Berkowitz, Marilyn R. Bernstein, O Laborde,

PubMed

1994

51

Predictors of persistent disease in women with complete hydatidiform mole.

A. Ayhan, Tuncer Zs, H Halilzade,

PubMed

1996

42

Page 1